TOFACITINIB IN REFRACTORY JUVENILE DERMATOMYOSITIS

被引:0
|
作者
Lee, Kelley S. [1 ]
Patel, Aarat M. [1 ,2 ]
机构
[1] Bon Secours Mercy Hlth, Richmond, VA USA
[2] Univ Virginia, Dept Pediat, Charlottesville, VA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-69
引用
收藏
页码:523 / 523
页数:1
相关论文
共 50 条
  • [1] Refractory juvenile dermatomyositis: Response to tofacitinib
    Zhou, Qingfang
    Weng, Ruohang
    Xia, Yu
    MEDICINA CLINICA, 2022, 158 (02): : 95 - 96
  • [2] TOFACITINIB TREATMENT IN REFRACTORY JUVENILE DERMATOMYOSITIS: A CASE SERIES
    Bowler, Hailey A.
    Patel, Aarat M.
    RHEUMATOLOGY, 2021, 60
  • [3] TREATMENT OF REFRACTORY DERMATOMYOSITIS WITH TOFACITINIB
    Riggle, K.
    Patel, A.
    Aggarwal, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1592 - 1592
  • [4] Refractory juvenile dermatomyositis
    Ilowite, NT
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 18 - 18
  • [5] SUCCESSFUL MANAGEMENT WITH TOFACITINIB IN ADULT AND JUVENILE DERMATOMYOSITIS
    Bowler, Hailey
    Patel, Aarat
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 492 - 492
  • [6] Good Response to Tofacitinib in Refractory Amyopathic Dermatomyositis
    Crespo Cruz, A.
    del Boz, J.
    Romero Gomez, C.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (04): : 374 - 376
  • [7] A Retrospective Review of Tofacitinib in the Treatment of Refractory Dermatomyositis
    Plante, John
    Eason, Chelsea
    Santa Lucia, Gabriella
    Robinson, India
    Elston, Dirk
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (10) : 1133 - 1134
  • [8] Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: a pilot study and literature review
    Yu, Zhongxun
    Wang, Lin
    Quan, Meiying
    Zhang, Tiannan
    Song, Hongmei
    RHEUMATOLOGY, 2021, 60 (04) : 1700 - 1707
  • [9] Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China
    Zhang, Junmei
    Sun, Li
    Shi, XinWei
    Li, Shipeng
    Liu, Cuihua
    Li, Xiaoqing
    Lu, Meiping
    Deng, Jianghong
    Tan, Xiaohua
    Guan, Wanzhen
    Li, Guomin
    Wen, Xinran
    Liu, Ping
    Li, Caifeng
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [10] Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China
    Junmei Zhang
    Li Sun
    XinWei Shi
    Shipeng Li
    Cuihua Liu
    Xiaoqing Li
    Meiping Lu
    Jianghong Deng
    Xiaohua Tan
    Wanzhen Guan
    Guomin Li
    Xinran Wen
    Ping Liu
    Caifeng Li
    Arthritis Research & Therapy, 25